2 AI Healthcare Stocks to Buy Right Now
While the advent of artificial intelligence (AI) has obviously changed the world, not every utilization of AI has…
Transposon’s $22m ARPA-H award to test aging-fighting drug
The federal grant will fund TPN-101 studies aimed at helping people stay healthier and sharper as they age.…
A large-scale database for clinical trial outcomes and features
Global R&D expenditure for pharmaceuticals. Statista https://www.statista.com/statistics/309466/global-r-and-d-expenditure-for-pharmaceuticals/#::̃text=In%202022%2C%20research%20and%20development,principal%20agency%20associated%20with%20processes (2025). Grand View Research Clinical trials market size, share & trends…
SuppCo launches certification to verify actives in dietary supplements
The new program complements SuppCo’s TrustScore supplement quality rating system and builds on earlier testing initiatives, which revealed…
Stilbenoid gaylussacin modulates particulate matter-induced chromatin remodeling in macrophages to suppress chronic obstructive pulmonary disease
Chronic obstructive pulmonary disease (COPD), a leading cause of mortality worldwide, is characterized by chronic bronchitis and emphysema.1…
AI in drug repurposing: Cancer survival pledge
image: ©BlackJack3D | iStock Dr Shivan Sivakumar emphasises the need to rethink cancer care, advocating for the use…
RNA-targeting small molecules: a new frontier of drug discovery
Historically, drug discovery has centred around proteins but as targets become increasing saturated, novel RNA-targeting drugs indicate potential…
This Pharma Giant Is Using AI to Dominate Drug Discovery
There’s no denying modern-day artificial intelligence (AI) is doing some pretty cool stuff. But, to say it’s been…
Takeda deepens AI drug discovery push with $1.7 billion Iambic deal
By Kamal Choudhury Feb 9 (Reuters) – Privately held Iambic said on Monday it has entered a multi-year…
Marty Makary addresses staff concerns over drug voucher program
WASHINGTON — At an employee town hall on Tuesday, Food and Drug Administration leaders tried to quell staff…
Roche moves obesity drug to pivotal trials after mid-stage success
Andrew Joseph covers health, medicine, and the biopharma industry in Europe. You can reach Andrew on Signal at…
Synthetic Cannabinoid Comes Without the Side Effects
Northeastern University researchers have made a breakthrough drug discovery, developing the first synthetic endogenous cannabinoid compound, with repercussions…